文献速递妇科

卵巢癌手术并发症生活质量相关健康效用值的测定

Determination of quality of life-related health utilities for surgical complications in ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2024-02-19

研究评估卵巢癌患者、临床医生和非癌症对照对14种手术并发症的健康状态效用值,采用视觉模拟量表(VAS)和时间权衡法(TTO)。共50例患者、50名临床医生和50名对照参与。VAS评分中位数低于TTO评分(p<0.01)。临床医生VAS总体效用评分高于患者(0.49 vs 0.43,p<0.01),TTO无差异。患者与对照总体效用评分无差异。

要点

  • VAS评分中位数在所有组中均低于TTO评分(p<0.01)。
  • 临床医生VAS总体效用评分高于患者(0.49 vs 0.43,p<0.01)。
  • 未经历某种手术并发症的患者对造口的效用评分低于经历过的患者(0.2 vs 0.7,p=0.02)。

核心结论

  • 本研究建立了卵巢癌相关手术并发症的健康状态效用值,可用于未来成本效果评价以确定质量调整结局,并可能有助于共享决策过程中的患者咨询。

研究设计与样本

  • 评估卵巢癌患者、临床医生和非癌症对照对14种手术并发症的效用值,使用视觉模拟量表(VAS)和时间权衡法(TTO),效用值转换为0至1量表(0表示最不利结局,1表示最有利结局)。
  • 共50例患者、50名临床医生和50名对照参与。

主要发现

  • VAS评分中位数在所有组中均低于TTO评分(p<0.01)。
  • 患者认为「需要输血的出血」最有利(VAS效用值0.75),随后依次为疝、血栓栓塞、胸腔积液、脓肿、肠梗阻/肠麻痹、伤口感染、需要手术的肠梗阻、需要引流的吻合口漏、临时造口、需要手术的吻合口漏、泌尿生殖道瘘、永久造口和生殖肠道瘘(VAS效用值0.2)。
  • 临床医生VAS总体效用评分高于患者(0.49 vs 0.43,p<0.01),但TTO无差异。
  • 患者与对照总体效用评分无差异。
  • 未经历某种手术并发症的患者对造口的效用评分低于经历过的患者(0.2 vs 0.7,p=0.02)。

临床怎么用

  • 这些效用值可用于未来成本效果评价以确定质量调整结局,并可能有助于共享决策过程中的患者咨询。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the health state utilities of ovarian cancer patients, clinicians, and non-cancer controls regarding surgical complications in ovarian cancer. METHODS: Utilities for 14 surgical complications were assessed from patients with recently diagnosed or recurrent ovarian cancer, clinicians, and non-cancer controls using the visual analog scale (VAS) and time trade-off (TTO) methods. Health state utilities were converted to a 0-to-1 scale, where 0 represents the least favorable outcome and 1 represents the most favorable outcome. RESULTS: Fifty patients, 50 clinicians, and 50 controls participated. Median VAS scores were lower than TTO scores across all groups (p < 0.01). Patients viewed 'bleeding requiring transfusion' most favorably (VAS utility 0.75), followed in order by less favorable utility scores for hernia, thromboembolism, pleural effusion, abscess, ileus/bowel obstruction, wound infection, bowel obstruction requiring surgery, anastomotic leak requiring drain, temporary ostomy, anastomotic leak requiring surgery, genito-urinary fistula, permanent ostomy, and genito-intestinal fistula (VAS utility 0.2). Overall, clinicians perceived complications more favorably than patients by VAS (overall utility score 0.49 vs 0.43, p < 0.01), but not by the TTO. There were no differences in overall utility scores between patients and controls. Patients who had not experienced certain surgical complications had less favorable scores than patients who did (utility score for ostomy = 0.2 for patients without ostomy vs. 0.7 for patients with ostomy, p = 0.02). CONCLUSIONS: This study establishes health state utilities for surgical complications associated with ovarian cancer. These utilities can be used in future cost-effectiveness evaluations to determine quality-adjusted outcomes and may help in counseling patients during the shared decision-making process.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Suidan RS, Sun CC, Schneider AK, et al. Determination of quality of life-related health utilities for surgical complications in ovarian cancer. Gynecol Oncol. 2024. PMID: 38377761. doi:10.1016/j.ygyno.2024.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。